Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies.

Eleftheria KampouriJessica S LittleKai RejeskiOriol ManuelSarah P HammondJoshua A Hill

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2023)

Risk stratification tools are available and may help distinguish between infectious and non-infectious causes of fever post-infusion and predict severe infections. These tools need prospective validation, and their integration in clinical practice needs to be systematically studied.

Keyphrases

cell therapy
clinical practice
stem cells
mesenchymal stem cells
early onset
bone marrow